Shopping Cart
- Remove All
- Your shopping cart is currently empty
UC-514321 directly targets STAT3/5 and represses TET1 expression. UC-514321 has the potential to treat acute myeloid leukemia (AML) both in vitro and in vivo, with low toxicity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $85 | In Stock | |
5 mg | $198 | In Stock | |
10 mg | $376 | In Stock | |
25 mg | $637 | In Stock | |
50 mg | $888 | In Stock | |
100 mg | $1,230 | In Stock | |
1 mL x 10 mM (in DMSO) | $229 | In Stock |
Description | UC-514321 directly targets STAT3/5 and represses TET1 expression. UC-514321 has the potential to treat acute myeloid leukemia (AML) both in vitro and in vivo, with low toxicity. |
In vitro | UC-514321 (0-500 nM, 48 h) inhibits AML cells viability TET1-signaling dependently.UC-514321 increases apoptosis in AML cells not in normal HSPCs. |
In vivo | In AML mice models, UC-514321 (2.5 mg/kg, i.p., once per day, for 10 days) exhibits more potent anti-tumor activity than NSC370284. |
Molecular Weight | 441.56 |
Formula | C26H35NO5 |
Cas No. | 299420-83-0 |
Smiles | CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(N1CCOCC1)c1cc2OCOc2cc1O |
Relative Density. | 1.186 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 25 mg/mL (55.62 mM), Sonication is recommended. H2O: 50 mg/mL (113.23 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.